Metformin and sitAgliptin in patients with impAired glucose tolerance and a recent TIA or minor ischemic Stroke (MAAS): study protocol for a randomized controlled trial

Overview of attention for article published in Trials, August 2015

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 104 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Non-Pioglitazone Antihyperglycemic Agents for Secondary Prevention of Stroke in Type II Diabetes or Pre-Diabetes: Clinical Effectiveness and Cost-Effectiveness

Cited by Canadian Agency for Drugs and Technologies in Health on 27 Jul 2020

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.